This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Western University directory, so their courses and email address may be missing. Find their university profile.
Latest papers
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
Journal of Clinical Oncology · 2018 · senior author
Latest funding
- $1,995,001
Integrated Precision Medicine Technology and Approach for Optimal Drug Therapy for Canadians
CIHR · 2020 · Principal investigator
1 publications.
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
Young AM, Marshall A, Thirlwall J, Chapman O, Lokare A, Hill C, Hale D, Dunn JA, Lyman GH, Hutchinson C
Integrated Precision Medicine Technology and Approach for Optimal Drug Therapy for Canadians
Principal investigators: Kim, Richard B; Barrett, David R; Bauman, Glenn S; Choi, Yun-Hee; Garg, Amit; Grof-Iannelli, Martie N; Levine, Mark N; Morgan, Bronagh J; Sarma, Sisira K; Schwarz, Ute I; Tirona, Rommel G; Welch, Stephen A; Winquist, Eric
Keywords: Clinical Pharmacology; Drug Interactions; Drug Metabolism; Pharmacogenetics; Pharmacogenomics
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.